newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics to Present Clinical Data at the 62nd American Society of Hematology Annual Meeting

CAMBRIDGE, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of...